首頁 › B細胞淋巴瘤 › 紐約州 › New York City
New York City, NY 的 B細胞淋巴瘤 臨床試驗
18 項針對 B細胞淋巴瘤 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
招募中3 期
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
招募中2 期
- Research Site, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
招募中1/2 期
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- 還有 1 項
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
招募中1 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
招募中1/2 期
- Research Site, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
招募中1 期
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
招募中1/2 期
- Research Site, New York
A Study of ARC-02 in B-cell NHL
招募中1 期
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
招募中1/2 期
- Research Site, New York
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
招募中1/2 期
- Memorial Sloan Kettering, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
招募中2 期
- Columbia University Irving Medical Center, New York
Study of CAR-T Therapy in Older Patients
招募中觀察性研究
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
招募中
- Columbia University, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
招募中
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
其他城市的 B細胞淋巴瘤 試驗
- Houston, TX16 項研究
- Chicago, IL13 項研究
- Nashville, TN11 項研究
- Philadelphia, PA11 項研究
- Rochester, MN10 項研究
- Baldwin Park, CA9 項研究
- Milwaukee, WI9 項研究
- Cleveland, OH9 項研究
- Boston, MA8 項研究
- Salt Lake City, UT8 項研究
- Washington, DC7 項研究
- Charlotte, NC7 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。